These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15548128)

  • 21. Why do COX-2 inhibitors increase risk of cardiovascular events?
    Frankish H
    Lancet; 2002 Apr; 359(9315):1410. PubMed ID: 11978344
    [No Abstract]   [Full Text] [Related]  

  • 22. The Vioxx debacle revisited.
    Daikh DI
    Am J Med; 2005 Sep; 118(9):1057. PubMed ID: 16164908
    [No Abstract]   [Full Text] [Related]  

  • 23. [A new pharmacological principle is effective--rofecoxib. Specific COX-2 inhibition].
    MMW Fortschr Med; 1999 Dec; 141(51-52):66-7. PubMed ID: 10949630
    [No Abstract]   [Full Text] [Related]  

  • 24. Merck withdraws arthritis drug worldwide.
    Singh D
    BMJ; 2004 Oct; 329(7470):816. PubMed ID: 15472245
    [No Abstract]   [Full Text] [Related]  

  • 25. Discontinuation of Vioxx.
    Kim PS; Reicin AS
    Lancet; 2005 Jan 1-7; 365(9453):23; author reply 26-7. PubMed ID: 15639669
    [No Abstract]   [Full Text] [Related]  

  • 26. The perioperative use of cyclooxygenase-2 selective nonsteroidal antiinflammatory drugs may offer a safer alternative.
    Reuben SS; Connelly NR
    Anesthesiology; 2004 Mar; 100(3):748. PubMed ID: 15109000
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute, anuric renal failure associated with two doses of a cyclooxygenase-2 inhibitor.
    Wahba AL; Soper C
    Nephron; 2001 Oct; 89(2):239. PubMed ID: 11549912
    [No Abstract]   [Full Text] [Related]  

  • 28. Wolf in sheep's clothing?
    Varga J
    Am J Hosp Palliat Care; 2000; 17(4):280. PubMed ID: 11883807
    [No Abstract]   [Full Text] [Related]  

  • 29. [Thinking about the specific cyclooxygenase-2 inhibitors since its recommendation].
    Shi G
    Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):579-80. PubMed ID: 11758234
    [No Abstract]   [Full Text] [Related]  

  • 30. A world without Vioxx: to COX-2 or not to COX-2?
    Simon LS; Strand V
    Cleve Clin J Med; 2004 Nov; 71(11):849-50, 852, 854 passim. PubMed ID: 15570734
    [No Abstract]   [Full Text] [Related]  

  • 31. The coxibs, selective inhibitors of cyclooxygenase-2.
    FitzGerald GA; Patrono C
    N Engl J Med; 2001 Aug; 345(6):433-42. PubMed ID: 11496855
    [No Abstract]   [Full Text] [Related]  

  • 32. The coxibs, selective inhibitors of cyclooxygenase-2.
    Killen JP
    N Engl J Med; 2001 Dec; 345(23):1708; author reply 1709. PubMed ID: 11759656
    [No Abstract]   [Full Text] [Related]  

  • 33. Probable rofecoxib-induced thrombocytopenia.
    Kentos A; Robin V; Lambermont M; Jurdan M; Pignarelli M; Feremans W
    Rheumatology (Oxford); 2003 May; 42(5):699-700. PubMed ID: 12709555
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute urinary retention associated with the use of cyclooxygenase-2 inhibitors.
    Gruenenfelder J; McGuire EJ; Faerber GJ
    J Urol; 2002 Sep; 168(3):1106. PubMed ID: 12187239
    [No Abstract]   [Full Text] [Related]  

  • 35. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
    MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
    [No Abstract]   [Full Text] [Related]  

  • 36. Under surveillance.
    Nat Biotechnol; 2005 Jan; 23(1):1. PubMed ID: 15637596
    [No Abstract]   [Full Text] [Related]  

  • 37. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
    Zeidler H
    MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521
    [No Abstract]   [Full Text] [Related]  

  • 38. VIOXX and cardiovascular events: a class effect?
    Berenbaum F
    Joint Bone Spine; 2005 Jan; 72(1):1-3. PubMed ID: 15681239
    [No Abstract]   [Full Text] [Related]  

  • 39. [Cyclooxygenase inhibitors: a never ending story?].
    Macrì R; Manfredi C
    G Ital Cardiol (Rome); 2006 Jul; 7(7):505-7. PubMed ID: 16977790
    [No Abstract]   [Full Text] [Related]  

  • 40. Anaphylactoid reaction to a cyclooxygenase-2 inhibitor in a patient who had a reaction to a cyclooxygenase-1 inhibitor.
    Schellenberg RR; Isserow SH
    N Engl J Med; 2001 Dec; 345(25):1856. PubMed ID: 11752370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.